Larvol Delta - A-Study-of-Ocrelizumab-in-Children-and-Adolescents-With-RelapsingRemitting-Multiple-Sclerosis

Ocrevus (ocrelizumab) - Roche

http://clinicaltrials.gov/ct2/show/NCT04075266

Sep 15, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next